Metabolic Syndrome and Inflammation: Interrelated Aspects and Biomarkers Involved
- Authors: Jose Pedregosa Díaz, María Henar García-Lagunar, María Dolores Albaladejo-Otón3
-
View Affiliations Hide Affiliations3 Clinical Analysis Department, Santa Lucia General University Hospital, Cartagena, Spain
- Source: New Trends In Biomarkers and Diseases Research: An Overview , pp 23-56
- Publication Date: September 2017
- Language: English
Metabolic Syndrome and Inflammation: Interrelated Aspects and Biomarkers Involved, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9781681084954/chapter-2-1.gif
Metabolic syndrome is considered a cluster of cardiovascular risk factors that are presented both in a single individual. They include insulin resistance, type 2 diabetes mellitus, dyslipidemia, hypertension and central obesity. Metabolic syndrome is related to systemic alterations that involve several tissues, such as liver, muscle, adipose tissue, stomach and immune system, varying the production of many biomolecules. Due to the main outcome of this clinical state being cardiovascular disease, metabolic syndrome has become a significant clinical priority.This global disturbance can be first detected and monitored later by several plasmatic biomarkers. This chapter intends to review a battery of avant-garde biomarkers related to metabolic syndrome.
-
From This Site
/content/books/9781681084954.chapter-2dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
